Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) have a high incidence and mortality rate, and investigating the pathogenesis and potential therapeutic strategies of HNSCC is required for further progress. Immunotherapy is a considerable therapeutic strategy for HNSCC due to its potential to produce a...
Main Authors: | Chenhang Yu, Qiang Li, Yu Zhang, Zhi-Fa Wen, Heng Dong, Yongbin Mou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2022.941750/full |
Similar Items
-
MicroRNAs in Head and Neck Squamous Cell Carcinoma (HNSCC) and Oral Squamous Cell Carcinoma (OSCC)
by: Masashi Shiiba, et al.
Published: (2010-04-01) -
Exploring the frontiers: tumor immune microenvironment and immunotherapy in head and neck squamous cell carcinoma
by: Shaokun Liu, et al.
Published: (2024-01-01) -
Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
by: Barbara Seliger, et al.
Published: (2020-09-01) -
Treatment Response of Gingival Squamous-Cell Carcinoma to Palliative Intent Immunotherapy
by: Natalia Trehan, et al.
Published: (2023-12-01) -
Synergy of electrochemotherapy and immunotherapy in the treatment of skin squamous cell carcinoma of the head and neck
by: Ida Barca, et al.
Published: (2023-12-01)